Crizotinib - PDFSEARCH.IO - Document Search Engine

Crizotinib
Results: 74

#	Item
31	Microsoft PowerPoint - NWallis TAT O11-5 Final Add to Reading List Source URL: astx.com Language: English - Date: 2014-06-09 11:38:56 Organofluorides Piperidines Lung cancer Crizotinib Pyrazoles Protein kinase inhibitor Anaplastic lymphoma kinase Erlotinib Hsp90 Chemistry Organic chemistry Pfizer
32	November 2012 Volume 16, Issue 9 The investment report that gives you the essenƟals to wisely invest in biotechnology securiƟes. Add to Reading List Source URL: www.biotechnav.com Language: English - Date: 2013-01-16 17:13:33 Alkynes Amines Piperazines Organochlorides AP26113 Gefitinib Erlotinib Crizotinib Non-small-cell lung carcinoma Chemistry Organic chemistry Organofluorides
33	2014_AT13387_poster_ESMO_abst_1231_Besse_final Add to Reading List Source URL: astx.com Language: English - Date: 2014-09-27 03:30:14 Piperidines Crizotinib Pyrazoles Pyridines Organic chemistry Biology Anaplastic lymphoma kinase Hsp90 Non-small-cell lung carcinoma Chemistry Organofluorides Organochlorides
34	Public Summary Document Application No[removed] – Testing of the anaplastic lymphoma kinase (ALK) gene in patients with non–small cell lung cancer to determine eligibility for treatment with crizotinib Add to Reading List Source URL: www.msac.gov.au Language: English Lung cancer Organofluorides Organochlorides Anatomical pathology Crizotinib Pyrazoles Non-small-cell lung carcinoma Anaplastic lymphoma kinase Protein kinase inhibitor Medicine Oncology Chemistry
35	1250 Consultation Decision Analytic Protocol (DAP) to guide the assessment of diagnostic testing for Anaplastic Lymphoma Kinase (ALK) gene rearrangement in patients with advanced non-small cell lung cancer to determine e Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:14 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Crizotinib Non-small-cell lung carcinoma Anaplastic lymphoma kinase Protein kinase inhibitor Medicine Chemistry Oncology
36	Public Summary Document Application No. 1250 – Testing of the anaplastic lymphoma kinase (ALK) gene in patients with non–small cell lung cancer to determine eligibility for treatment with crizotinib Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:15 Anatomical pathology Organofluorides Organochlorides Pfizer Crizotinib Anaplastic lymphoma kinase Non-small-cell lung carcinoma Protein kinase inhibitor Squamous-cell carcinoma Medicine Oncology Lung cancer
37	1250 Consultation Decision Analytic Protocol (DAP) to guide the assessment of diagnostic testing for Anaplastic Lymphoma Kinase (ALK) gene rearrangement in patients with advanced non-small cell lung cancer to determine e Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-03-20 01:49:45 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Crizotinib Non-small-cell lung carcinoma Anaplastic lymphoma kinase Protein kinase inhibitor Medicine Chemistry Oncology
38	Instructions for Use Archer™ FusionPlex™ ALK, RET, ROS1 Panel v2 AK0028-8 Description Add to Reading List Source URL: archerdx.com Language: English - Date: 2015-02-19 18:39:00 ALK inhibitor Anaplastic lymphoma kinase Protein kinase inhibitor Crizotinib Tyrosine kinase ALK Organic chemistry ROS1 Illumina Biology Chemistry Organofluorides
39	Microsoft Word[removed]ALK-Final DAP.docx Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-03-20 01:49:46 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Crizotinib Non-small-cell lung carcinoma Anaplastic lymphoma kinase ALK inhibitor Medicine Chemistry Oncology
40	Microsoft Word[removed]Consultation DAP - ratified.doc Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:15 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Non-small-cell lung carcinoma Crizotinib Gefitinib Anaplastic lymphoma kinase Medicine Chemistry Oncology

UPDATE